Clinical Trials Logo

Axial Spondyloarthritis clinical trials

View clinical trials related to Axial Spondyloarthritis.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05119712 Withdrawn - Clinical trials for Ankylosing Spondylitis

Terbinafine Treatment of Axial Spondyloarthropathy

FUN
Start date: March 9, 2021
Phase: Early Phase 1
Study type: Interventional

This is a pilot study to determine if further research is warranted to assess if anti-fungal therapy is an effective adjunctive treatment for axial spondyloarthropathy

NCT ID: NCT02429882 Withdrawn - Clinical trials for Axial Spondyloarthritis

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis

Start date: May 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of brodalumab compared with placebo in participants with axial spondyloarthritis. Subjects will be randomized in a 1:1 ratio to brodalumab or placebo for the first part of the study. Subjects will then receive open label brodalumab for the remainder of the study. The entire study will be 312 weeks in duration for each subject.